DANIEL K SPIEGELMAN Insider Trading $RLYP Relypsa Inc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DANIEL K SPIEGELMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DANIEL K SPIEGELMAN. DANIEL K SPIEGELMAN is Senior Vice President and CFO in CV THERAPEUTICS INC ($CVTX) and Director in MYRIAD GENETICS INC ($MYGN) and EVP, Chief Financial Officer in BIOMARIN PHARMACEUTICAL INC ($BMRN) and Director in Oncothyreon Inc. ($ONTY) and Director in Relypsa Inc ($RLYP).
DANIEL K SPIEGELMAN in Relypsa Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL K SPIEGELMAN: Director
Holdings: 2,250 shares
Latest Transaction: Sep 02 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DANIEL K SPIEGELMAN in Relypsa Inc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BMRN, CASC, CVTX, MYGN, RLYP
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 02 2016 | RLYP | Relypsa Inc | SPIEGELMAN DANIEL K | Director | Option Exercise | D | 17.00 | 4,500 | 76,500 | 0 | |
| Sep 02 2016 | RLYP | Relypsa Inc | SPIEGELMAN DANIEL K | Director | Option Exercise | D | 35.79 | 4,500 | 161,055 | 0 | |
| Sep 02 2016 | RLYP | Relypsa Inc | SPIEGELMAN DANIEL K | Director | Option Exercise | D | 23.96 | 12,000 | 287,520 | 0 | |
| Sep 02 2016 | RLYP | Relypsa Inc | SPIEGELMAN DANIEL K | Director | Sell | D | 32.00 | 2,250 | 72,000 | 0 | 2.3 K to 0 (-100.00 %) |
| Sep 02 2016 | RLYP | Relypsa Inc | SPIEGELMAN DANIEL K | Director | Sell | U | 32.00 | 1,237 | 39,584 | 2,250 | 3.5 K to 2.3 K (-35.47 %) |
| Jun 23 2016 | RLYP | Relypsa Inc | SPIEGELMAN DANIEL K | Director | Option Exercise | A | 17.00 | 4,500 | 76,500 | 4,500 | |
| Jun 23 2016 | RLYP | Relypsa Inc | SPIEGELMAN DANIEL K | Director | Grant | A | 0.00 | 2,250 | 0 | 3,487 | 1.2 K to 3.5 K (+181.89 %) |
| Jun 08 2016 | RLYP | Relypsa Inc | SPIEGELMAN DANIEL K | Director | Sell | S | 19.31 | 1,013 | 19,562 | 1,237 | 2.3 K to 1.2 K (-45.02 %) |
| Jun 08 2015 | RLYP | Relypsa Inc | SPIEGELMAN DANIEL K | Director | Option Exercise | A | 35.79 | 4,500 | 161,055 | 4,500 | |
| Jun 08 2015 | RLYP | Relypsa Inc | SPIEGELMAN DANIEL K | Director | Grant | A | 0.00 | 2,250 | 0 | 2,250 | 0 to 2.3 K |
Page: 1